What is Tirzepatide?

Introduction

Tirzepatide is an injectable medication that helps control blood sugar levels and promotes weight loss. It’s sold under the brand names Mounjaro (for type 2 diabetes) and Zepbound (for weight management).

What makes tirzepatide different from similar medications is that it activates two hormone receptors instead of one, potentially making it more effective for some people.

---

How Does Tirzepatide Work?

Tirzepatide works by mimicking two natural hormones your body produces after eating:

GLP-1 (Glucagon-Like Peptide-1)

• Signals your pancreas to release insulin when blood sugar rises
• Slows down how quickly food leaves your stomach
• Helps you feel full longer

GIP (Glucose-Dependent Insulinotropic Polypeptide)

• Also helps release insulin when blood sugar is elevated
• May have additional effects on fat metabolism

By activating both of these pathways, tirzepatide is called a dual incretin agonist.

In simple terms: Tirzepatide helps your body better control blood sugar and reduces appetite, leading to improved diabetes control and weight loss.

---

What is Tirzepatide Used For?

FDA-Approved Uses

Condition	Brand Name	Approved
Type 2 Diabetes	Mounjaro	May 2022
Chronic Weight Management	Zepbound	November 2023

For Type 2 Diabetes

Tirzepatide is approved for adults with type 2 diabetes to improve blood sugar control. It can be used:

• As a single medication (monotherapy)
• Combined with other diabetes medications
• As an addition to diet and exercise

For Weight Management

Tirzepatide (as Zepbound) is approved for adults with:

• Obesity (BMI of 30 or higher)
• Overweight (BMI of 27 or higher) with at least one weight-related health condition

---

How is Tirzepatide Administered?

Injection Details

• Method: Subcutaneous injection (under the skin)
• Frequency: Once weekly (same day each week)
• Injection sites: Abdomen, thigh, or upper arm
• Device: Pre-filled pen (single-use)

Dosing Schedule

Tirzepatide uses a gradual dose increase to minimize side effects:

Weeks	Dose	Purpose
1-4	2.5 mg	Starting dose
5-8	5 mg	First increase
9-12	7.5 mg	Second increase
13-16	10 mg	Third increase
17+	12.5-15 mg	Maintenance (if needed)

Your doctor may adjust this schedule based on your response and tolerability.

---

What Does the Research Show?

For Diabetes Control

Clinical trials (called SURPASS) showed tirzepatide significantly lowered HbA1c (a measure of average blood sugar):

Trial	Result
SURPASS-1	1.9-2.1% reduction vs placebo
SURPASS-2	2.0-2.3% reduction (vs semaglutide 1mg: 1.9%)

Many participants achieved an HbA1c below 7%, the typical treatment goal.

For Weight Loss

Clinical trials (called SURMOUNT) showed substantial weight loss:

Trial	Population	Weight Loss (15mg dose)
SURMOUNT-1	Obesity, no diabetes	22.5% of body weight
SURMOUNT-2	Obesity with diabetes	15.7% of body weight

For perspective: In SURMOUNT-1, the average participant lost about 52 pounds (24 kg) over 72 weeks.

---

Is Tirzepatide Safe?

Like all medications, tirzepatide has potential side effects. The most common are related to the digestive system:

Common Side Effects

• Nausea (12-18% of people)
• Diarrhea (12-17%)
• Decreased appetite (5-10%)
• Vomiting (5-9%)
• Constipation (6-7%)

These side effects are usually mild to moderate and tend to improve over time, especially with gradual dose increases.

Serious Considerations

Tirzepatide carries a boxed warning about thyroid tumors observed in animal studies. While this hasn’t been confirmed in humans, people with certain thyroid conditions should not use it.

Not appropriate for:

• People with a personal or family history of medullary thyroid cancer
• People with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• People with known hypersensitivity to tirzepatide

For complete safety information, see our GLP-1 Safety Overview.

---

Key Takeaways

1. What it is: A once-weekly injectable medication that activates both GIP and GLP-1 receptors

2. What it’s for: FDA-approved for type 2 diabetes (Mounjaro) and weight management (Zepbound)

3. How well it works: Clinical trials show significant improvements in blood sugar control and weight loss

4. Common side effects: Mostly digestive (nausea, diarrhea) that often improve over time

5. How it’s given: Weekly injection that starts at a low dose and increases gradually

6. Important note: This is a prescription medication that should only be used under medical supervision

---

Learn More

• Tirzepatide Evidence Dossier - Complete research summary with citations
• GLP-1 Safety Overview - Detailed safety information
• Tirzepatide vs Semaglutide - Side-by-side comparison

---

This guide is for educational purposes only. Consult a healthcare provider to discuss whether tirzepatide is appropriate for you.